About_Us
PROCYL THERAPEUTICS
At Procyl Therapeutics, we are driven by a simple yet profound mission: we care, we cure. Founded in 2024 by a team of scientists and industry professionals Dr. Sivapriya Kirubakaran, Dr. Vijay Thiruvenkatam, Mr. Dharmeshkumar Patel, and Dr. Ripal Khamar, our aim is to discover and develop new treatments for cancer and other life-threatening diseases.
Our focus is clear: to meet medical needs by creating therapies that are both effective and affordable. We are especially committed to improving the lives of patients in India and beyond. Our work is based on innovation, with the goal of turning academic research into treatments that make a real difference in healthcare.
The Procyl Therapeutics journey is built on years of research, which has resulted in 14 Indian patents and one US patent. These achievements motivate us to turn our intellectual property into real-world therapies that can shape the future of healthcare. Our expertise lies in drug discovery, microbiology, bio-analytics, and small molecule synthesis. With these strengths, we focus on developing therapies that are modern, safe, and high-quality. By aligning with the “Make in India” initiative, we are proud to contribute to local innovation and help strengthen India’s role in the global pharmaceutical industry.
We are also working to build partnerships with academic institutions, research organizations, and industry players to speed up our R&D efforts. By joining hands, we hope to tackle the challenges of drug discovery and bring new treatments to patients faster. While cancer drug discovery is our primary focus, we are also looking ahead to offer treatments for other serious diseases. Our goal is to improve lives and create a healthier future for everyone.
Quick Contact
If you have any questions or need help, feel free to contact with our team.
Send Us Email:
English